Skip to content

   Pharma Publications

Neuropsychopharmacology
  • nNOS-expressing neurons in the mPFC mediate depression-related behaviors in mice through pPVT-mPFC projections
    Published on 2025-07-08
    1 year ago
  • Distinct subpopulations of parvalbumin neurons participating in divergent prefrontal functions
    Published on 2025-07-07
    1 year ago
  • Cocaine self-administration in adult female and male rhesus monkeys: longitudinal comparison with adolescent behavior and role of early life stress
    Published on 2025-07-05
    1 year ago
  • To indulge or enrich: how environmental enrichment affects neurons that promote food seeking
    Published on 2025-07-04
    1 year ago
  • Impact of early social isolation on social circuits and behavior: relevance to schizophrenia
    Published on 2025-07-04
    1 year ago
  • Prefrontal cortex development and its implications in mental illness
    Published on 2025-07-03
    1 year ago
  • High hopes, hard realities: cannabidiol shows no acute effects in youth with alcohol use disorder
    Published on 2025-07-03
    1 year ago
« Previous 1 … 48 49 50 51 52 … 143 Next »
Journal of Psychopharmacology
  • The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms
    Published on 2024-06-03
    2 years ago
  • Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights
    Published on 2024-05-28
    2 years ago
  • Changes in processing speed during early abstinence from alcohol dependence
    Published on 2024-05-28
    2 years ago
  • Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)
    Published on 2024-05-14
    2 years ago
  • Aripiprazole for treating delirium: A systematic review—Is it a valid yet understudied treatment?
    Published on 2024-04-30
    2 years ago
  • Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice
    Published on 2024-04-29
    2 years ago
  • Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database
    Published on 2024-04-28
    2 years ago
« Previous 1 … 48 49 50 51 52 … 150 Next »
European Neuropsychopharmacology
  • Single-arm meta-analysis of drug response in placebo-controlled versus active-controlled antipsychotic drug trials in schizophrenia
    Published on 2024-04-21
    2 years ago
  • Challenges in testing concentrated cognitive-behaviour therapy for unmedicated adults with obsessive-compulsive disorder in routine care
    Published on 2024-04-21
    2 years ago
  • Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents
    Published on 2024-04-21
    2 years ago
  • Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials
    Published on 2024-04-21
    2 years ago
  • Schizophrenia patients are not benefiting from worldwide improvements in life expectancy
    Published on 2024-04-21
    2 years ago
  • Cognitive screening in bipolar disorder
    Published on 2024-04-21
    2 years ago
  • Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis
    Published on 2024-04-20
    2 years ago
« Previous 1 … 48 49 50 51 52 … 168 Next »

   Pharma Pub